Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SURESCRIPTS via MCDERMOTT WILL & SCHULTE LLP
2026 · second_quarter · Q2
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Source: Senate LDA
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: SURESCRIPTS · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Equitable Community Access to Pharmacist Services Act.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SURESCRIPTS via MCDERMOTT WILL & SCHULTE LLP
2026 · first_quarter · Q1
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Equitable Community Access to Pharmacist Services Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SURESCRIPTS via MCDERMOTT WILL & SCHULTE LLP
2025 · fourth_quarter · Q4
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote equitable community access to pharmacist services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SURESCRIPTS via MCDERMOTT WILL & SCHULTE LLP
2025 · third_quarter · Q3
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote equitable community access to pharmacist services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SURESCRIPTS via MCDERMOTT WILL & SCHULTE LLP
2025 · second_quarter · Q2
Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.
Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote equitable community access to pharmacist services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2021 · fourth_quarter · Q4
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), White House Office
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2021 · third_quarter · Q3
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2021 · second_quarter · Q2
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2021 · first_quarter · Q1
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2020 · fourth_quarter · Q4
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
HIFU PROSTATE SERVICES, LLC via MCDERMOTT WILL & SCHULTE LLP
2020 · fourth_quarter · RR
Medicare reimbursement for HIFU (high intensity focused ultrasound) for localized prostate cancer.